 | • レポートコード：GIR-107A14648 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、慢性腎疾患治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。慢性腎疾患治療薬の種類別市場規模（ACE阻害薬、カルシウムチャネル遮断薬、ベータ遮断薬、その他）、用途別市場規模（病院、専門クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・慢性腎疾患治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Keryx Biopharmaceuticals, Inc、Kissei Pharmaceutical Co., Ltd、AbbVie、GlaxoSmithKline、Sanofi、F. Hoffmann-La Roche Ltd、Pfizer、AstraZeneca、Amgen、Teva Pharmaceutical Industries ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ACE阻害薬、カルシウムチャネル遮断薬、ベータ遮断薬、その他 ・用途別分析2016年-2026年：病院、専門クリニック ・慢性腎疾患治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・慢性腎疾患治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・慢性腎疾患治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・慢性腎疾患治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・慢性腎疾患治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chronic Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chronic Kidney Disease Drugs size is estimated to be xx million in 2021 from USD 11330 million in 2020, with a change of XX% between 2020 and 2021. The global Chronic Kidney Disease Drugs market size is expected to grow at a CAGR of 1.7% for the next five years.
Market segmentation
Chronic Kidney Disease Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Market segment by Application can be divided into
Hospitals
Specialty Clinics
The key market players for global Chronic Kidney Disease Drugs market are listed below:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Chronic Kidney Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Kidney Disease Drugs, with price, sales, revenue and global market share of Chronic Kidney Disease Drugs from 2019 to 2021.
Chapter 3, the Chronic Kidney Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Kidney Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Chronic Kidney Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Chronic Kidney Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Chronic Kidney Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Kidney Disease Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blockers
1.2.4 Beta Blockers
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Kidney Disease Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Global Chronic Kidney Disease Drugs Market Size & Forecast
1.4.1 Global Chronic Kidney Disease Drugs Sales in Value (2016-2026))
1.4.2 Global Chronic Kidney Disease Drugs Sales in Volume (2016-2026)
1.4.3 Global Chronic Kidney Disease Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Chronic Kidney Disease Drugs Production Capacity Analysis
1.5.1 Global Chronic Kidney Disease Drugs Total Production Capacity (2016-2026)
1.5.2 Global Chronic Kidney Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Kidney Disease Drugs Market Drivers
1.6.2 Chronic Kidney Disease Drugs Market Restraints
1.6.3 Chronic Kidney Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Keryx Biopharmaceuticals, Inc
2.1.1 Keryx Biopharmaceuticals, Inc Details
2.1.2 Keryx Biopharmaceuticals, Inc Major Business
2.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product and Services
2.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Kissei Pharmaceutical Co., Ltd
2.2.1 Kissei Pharmaceutical Co., Ltd Details
2.2.2 Kissei Pharmaceutical Co., Ltd Major Business
2.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product and Services
2.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Chronic Kidney Disease Drugs Product and Services
2.3.4 AbbVie Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Product and Services
2.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Chronic Kidney Disease Drugs Product and Services
2.5.4 Sanofi Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 F. Hoffmann-La Roche Ltd
2.6.1 F. Hoffmann-La Roche Ltd Details
2.6.2 F. Hoffmann-La Roche Ltd Major Business
2.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product and Services
2.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Chronic Kidney Disease Drugs Product and Services
2.7.4 Pfizer Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Chronic Kidney Disease Drugs Product and Services
2.8.4 AstraZeneca Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Chronic Kidney Disease Drugs Product and Services
2.9.4 Amgen Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product and Services
2.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Chronic Kidney Disease Drugs Sales by Manufacturer
3.1 Global Chronic Kidney Disease Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chronic Kidney Disease Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chronic Kidney Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Kidney Disease Drugs Manufacturer Market Share
3.4.2 Top 6 Chronic Kidney Disease Drugs Manufacturer Market Share
3.5 Global Chronic Kidney Disease Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chronic Kidney Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Kidney Disease Drugs Market Size by Region
4.1.1 Global Chronic Kidney Disease Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Chronic Kidney Disease Drugs Revenue by Region (2016-2026)
4.2 North America Chronic Kidney Disease Drugs Revenue (2016-2026)
4.3 Europe Chronic Kidney Disease Drugs Revenue (2016-2026)
4.4 Asia-Pacific Chronic Kidney Disease Drugs Revenue (2016-2026)
4.5 South America Chronic Kidney Disease Drugs Revenue (2016-2026)
4.6 Middle East and Africa Chronic Kidney Disease Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chronic Kidney Disease Drugs Sales in Volume by Type (2016-2026)
5.2 Global Chronic Kidney Disease Drugs Revenue by Type (2016-2026)
5.3 Global Chronic Kidney Disease Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chronic Kidney Disease Drugs Sales in Volume by Application (2016-2026)
6.2 Global Chronic Kidney Disease Drugs Revenue by Application (2016-2026)
6.3 Global Chronic Kidney Disease Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Kidney Disease Drugs Sales by Type (2016-2026)
7.2 North America Chronic Kidney Disease Drugs Sales by Application (2016-2026)
7.3 North America Chronic Kidney Disease Drugs Market Size by Country
7.3.1 North America Chronic Kidney Disease Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Chronic Kidney Disease Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Kidney Disease Drugs Sales by Type (2016-2026)
8.2 Europe Chronic Kidney Disease Drugs Sales by Application (2016-2026)
8.3 Europe Chronic Kidney Disease Drugs Market Size by Country
8.3.1 Europe Chronic Kidney Disease Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Chronic Kidney Disease Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chronic Kidney Disease Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Chronic Kidney Disease Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Chronic Kidney Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Chronic Kidney Disease Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chronic Kidney Disease Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chronic Kidney Disease Drugs Sales by Type (2016-2026)
10.2 South America Chronic Kidney Disease Drugs Sales by Application (2016-2026)
10.3 South America Chronic Kidney Disease Drugs Market Size by Country
10.3.1 South America Chronic Kidney Disease Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Chronic Kidney Disease Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Kidney Disease Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Chronic Kidney Disease Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Chronic Kidney Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Chronic Kidney Disease Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chronic Kidney Disease Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chronic Kidney Disease Drugs Typical Distributors
12.3 Chronic Kidney Disease Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Chronic Kidney Disease Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chronic Kidney Disease Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Keryx Biopharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Keryx Biopharmaceuticals, Inc Major Business
Table 5. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product and Services
Table 6. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Kissei Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Kissei Pharmaceutical Co., Ltd Major Business
Table 9. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product and Services
Table 10. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AbbVie Basic Information, Manufacturing Base and Competitors
Table 12. AbbVie Major Business
Table 13. AbbVie Chronic Kidney Disease Drugs Product and Services
Table 14. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Chronic Kidney Disease Drugs Product and Services
Table 18. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Chronic Kidney Disease Drugs Product and Services
Table 22. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 24. F. Hoffmann-La Roche Ltd Major Business
Table 25. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product and Services
Table 26. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Chronic Kidney Disease Drugs Product and Services
Table 30. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Chronic Kidney Disease Drugs Product and Services
Table 34. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Amgen Basic Information, Manufacturing Base and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Chronic Kidney Disease Drugs Product and Services
Table 38. Amgen Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product and Services
Table 42. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Chronic Kidney Disease Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 44. Global Chronic Kidney Disease Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Chronic Kidney Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Chronic Kidney Disease Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 47. Head Office and Chronic Kidney Disease Drugs Production Site of Key Manufacturer
Table 48. Chronic Kidney Disease Drugs New Entrant and Capacity Expansion Plans
Table 49. Chronic Kidney Disease Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Chronic Kidney Disease Drugs Sales by Region (2016-2021e) & (K MT)
Table 51. Global Chronic Kidney Disease Drugs Sales by Region (2021-2026) & (K MT)
Table 52. Global Chronic Kidney Disease Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Chronic Kidney Disease Drugs Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Chronic Kidney Disease Drugs Sales by Type (2016-2021e) & (K MT)
Table 55. Global Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (K MT)
Table 56. Global Chronic Kidney Disease Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Chronic Kidney Disease Drugs Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Chronic Kidney Disease Drugs Price by Type (2016-2021e) & (USD/MT)
Table 59. Global Chronic Kidney Disease Drugs Price by Type (2021-2026) & (USD/MT)
Table 60. Global Chronic Kidney Disease Drugs Sales by Application (2016-2021e) & (K MT)
Table 61. Global Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (K MT)
Table 62. Global Chronic Kidney Disease Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Chronic Kidney Disease Drugs Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Chronic Kidney Disease Drugs Price by Application (2016-2021e) & (USD/MT)
Table 65. Global Chronic Kidney Disease Drugs Price by Application (2021-2026) & (USD/MT)
Table 66. North America Chronic Kidney Disease Drugs Sales by Country (2016-2021e) & (K MT)
Table 67. North America Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (K MT)
Table 68. North America Chronic Kidney Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Chronic Kidney Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Chronic Kidney Disease Drugs Sales by Type (2016-2021e) & (K MT)
Table 71. North America Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (K MT)
Table 72. North America Chronic Kidney Disease Drugs Sales by Application (2016-2021e) & (K MT)
Table 73. North America Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (K MT)
Table 74. Europe Chronic Kidney Disease Drugs Sales by Country (2016-2021e) & (K MT)
Table 75. Europe Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (K MT)
Table 76. Europe Chronic Kidney Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Chronic Kidney Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Chronic Kidney Disease Drugs Sales by Type (2016-2021e) & (K MT)
Table 79. Europe Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (K MT)
Table 80. Europe Chronic Kidney Disease Drugs Sales by Application (2016-2021e) & (K MT)
Table 81. Europe Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (K MT)
Table 82. Asia-Pacific Chronic Kidney Disease Drugs Sales by Region (2016-2021e) & (K MT)
Table 83. Asia-Pacific Chronic Kidney Disease Drugs Sales by Region (2021-2026) & (K MT)
Table 84. Asia-Pacific Chronic Kidney Disease Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Chronic Kidney Disease Drugs Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Chronic Kidney Disease Drugs Sales by Type (2016-2021e) & (K MT)
Table 87. Asia-Pacific Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (K MT)
Table 88. Asia-Pacific Chronic Kidney Disease Drugs Sales by Application (2016-2021e) & (K MT)
Table 89. Asia-Pacific Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (K MT)
Table 90. South America Chronic Kidney Disease Drugs Sales by Country (2016-2021e) & (K MT)
Table 91. South America Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (K MT)
Table 92. South America Chronic Kidney Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Chronic Kidney Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Chronic Kidney Disease Drugs Sales by Type (2016-2021e) & (K MT)
Table 95. South America Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (K MT)
Table 96. South America Chronic Kidney Disease Drugs Sales by Application (2016-2021e) & (K MT)
Table 97. South America Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (K MT)
Table 98. Middle East & Africa Chronic Kidney Disease Drugs Sales by Country (2016-2021e) & (K MT)
Table 99. Middle East & Africa Chronic Kidney Disease Drugs Sales by Country (2021-2026) & (K MT)
Table 100. Middle East & Africa Chronic Kidney Disease Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Chronic Kidney Disease Drugs Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Chronic Kidney Disease Drugs Sales by Type (2016-2021e) & (K MT)
Table 103. Middle East & Africa Chronic Kidney Disease Drugs Sales by Type (2021-2026) & (K MT)
Table 104. Middle East & Africa Chronic Kidney Disease Drugs Sales by Application (2016-2021e) & (K MT)
Table 105. Middle East & Africa Chronic Kidney Disease Drugs Sales by Application (2021-2026) & (K MT)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Chronic Kidney Disease Drugs Typical Distributors
Table 109. Chronic Kidney Disease Drugs Typical Customers
List of Figures
Figure 1. Chronic Kidney Disease Drugs Picture
Figure 2. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2020
Figure 3. ACE Inhibitors
Figure 4. Calcium Channel Blockers
Figure 5. Beta Blockers
Figure 6. Others
Figure 7. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2020
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Global Chronic Kidney Disease Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Chronic Kidney Disease Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Chronic Kidney Disease Drugs Sales (2016-2026) & (K MT)
Figure 13. Global Chronic Kidney Disease Drugs Price by Type (2016-2026) & (USD/MT)
Figure 14. Global Chronic Kidney Disease Drugs Production Capacity (2016-2026) & (K MT)
Figure 15. Global Chronic Kidney Disease Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Chronic Kidney Disease Drugs Market Drivers
Figure 17. Chronic Kidney Disease Drugs Market Restraints
Figure 18. Chronic Kidney Disease Drugs Market Trends
Figure 19. Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturer in 2020
Figure 20. Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturer in 2020
Figure 21. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Chronic Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Chronic Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2016-2026)
Figure 25. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2016-2026)
Figure 26. North America Chronic Kidney Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Europe Chronic Kidney Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Chronic Kidney Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 29. South America Chronic Kidney Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Chronic Kidney Disease Drugs Revenue (2016-2026) & (USD Million)
Figure 31. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2016-2026)
Figure 32. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2016-2026)
Figure 33. Global Chronic Kidney Disease Drugs Price by Type (2016-2026) & (USD/MT)
Figure 34. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2016-2026)
Figure 35. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2016-2026)
Figure 36. Global Chronic Kidney Disease Drugs Price by Application (2016-2026) & (USD/MT)
Figure 37. North America Chronic Kidney Disease Drugs Sales Market Share by Type (2016-2026)
Figure 38. North America Chronic Kidney Disease Drugs Sales Market Share by Application (2016-2026)
Figure 39. North America Chronic Kidney Disease Drugs Sales Market Share by Country (2016-2026)
Figure 40. North America Chronic Kidney Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 41. United States Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Chronic Kidney Disease Drugs Sales Market Share by Type (2016-2026)
Figure 45. Europe Chronic Kidney Disease Drugs Sales Market Share by Application (2016-2026)
Figure 46. Europe Chronic Kidney Disease Drugs Sales Market Share by Country (2016-2026)
Figure 47. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 48. Germany Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Chronic Kidney Disease Drugs Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region (2016-2026)
Figure 57. China Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Chronic Kidney Disease Drugs Sales Market Share by Type (2016-2026)
Figure 64. South America Chronic Kidney Disease Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Chronic Kidney Disease Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Chronic Kidney Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Chronic Kidney Disease Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Chronic Kidney Disease Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Chronic Kidney Disease Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Chronic Kidney Disease Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Chronic Kidney Disease Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の末期腎疾患治療市場 2021：企業別、地域別、種類・用途別 The End-Stage Kidney Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 世界の腎臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Kidney Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のパーキンソン病治療薬市場 2021：企業別、地域別、種類・用途別 The Parkinsons Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のアルツハイマー病治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The worldwide market for Alzheimer's Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ i…
- 世界の腎疾患治療市場予測（～2024年） Scope of the Report: The global Renal Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…